ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2642

Rate and Predictors of Work Disability in Fibromyalgia

Frederick Wolfe1, Brian T. Walitt2, Robert S. Katz3 and Winfried Häuser4, 1National Data Bank for Rheumatic Diseases, Wichita, KS, 2Rheumatology, Washington Hospital Center, Washington, DC, 3Rush University Medical Center, Chicago, IL, 4Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Disability and fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia and Soft Tissue Disorders II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Fibromyalgia is a contested disorder whose diagnosis depends largely on self-report. It is reportedly also associated with a high rate of work disability, but there have been no detailed studies of work disability in fibromyalgia. In addition, disabled status is difficult to determine because there are no clearly observable abnormalities or reliable assessments methods to determine work disability. In this study we determined the rate of a work disability award and its predictors.

Methods : For up to 13 years, we studied a cohort of 2,322 fibromyalgia patients, who were between the ages of 21 and 64 years, using mailed and Internet questionnaires at 6-month intervals. 591 patients were receiving US Social Security disability (SSD) awards at entry to the cohort, and were not studied further. The remaining 1,730 constituted the study sample and were evaluated using Cox regression.

Results : For the entire sample (N=2,322) the prevalence of SSD was 34.8% (95% CI 32.9, 36.8). Over 13 years of follow-up of the non-disabled sample at study entry, a SSD prevalence of 25.5% was noted. The annual incidence rate for this group was 3.4% (3.0, 3.9%) annually and 25% of patients were disabled at 9.0 years (Figure 1). As shown in Table 1, a wide variety of univariate predictors (adjusted for age and sex) at the first observation were associated with future work disability, including younger age, abnormal mood, functional status as measured by the Health Assessment Questionnaire disability index (HAQ), increased BMI, current smoking, the polysymptomatic distress scale (PSD (“fibromyalgianess)), meeting ACR 2010 criteria, the SF-36 PCS and MCS scales, VAS fatigue, VAS pain, and rating one’s self as being disabled or being unemployed. College education was protective against future SSD. In multivariable Cox regression, only HAQ disability (Relative Risk 2.5 (1.8, 3.6)), rating one’s self as disabled (RR 5.9 (3.6, 9.7), and being unemployed (RR 3.3 (1.9, 5.8) were significant predictors of future SSD.

Conclusion: The receipt of a SSD award is common in fibromyalgia, with an annual incidence of 3.4% (3.0, 3.9%). Although many variables were predictive of SSD in univariate models, only self-report of functional status and current unemployment and/or self-reported disability predicted future SSD. One explanation for the few predictors is that BMI, smoking, education and symptoms contribute to functional status, which then dominates all other predictors.

Table 1. Univariate predictors of SSD, adjusted for age and sex

Variable

Hazard Ratio (95% CI)

Disabled – self-report  (yes/no)

10.5 (6.56, 16.67)

Unemployed (yes/no)

4.05 (2.34, 7.01)

FM Diagnostic criteria (+) (yes/no)

3.27 (2.27, 4.71)

Current smoking (yes/no)

1.70 (1.22, 2.35)

> High school education (yes/no)

0.71 (0.51, 0.98)

College education (yes/no)

0.46 (0.33, 0.66)

HAQ Disability (0-3)

4.77 (3.76, 6.04)

VAS Pain (0-10)

1.34 (1.25, 1.43)

Mood (0-10)

1.29 (1.21, 1.38)

VAS Fatigue (0-10)

1.22 (1.15, 1.30)

VAS Sleep disturbance (0-10)

1.18 (1.12, 1.24)

Polysymptomatic distress (0-31)

1.09 (1.07, 1.11)

Body mass index

1.04 (1.02, 1.05)

SF-36 PCS

0.92 (0.90, 0.93)

SF-36 MCS

0.96 (0.95, 0.97)

No ethnicity groups were statistically significant predictors.


Disclosure:

F. Wolfe,
None;

B. T. Walitt,
None;

R. S. Katz,
None;

W. Häuser,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rate-and-predictors-of-work-disability-in-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology